Geoffrey Dusheiko

Active 1979–2025

94
Papers
29,036
Citations
77
h-index
91
i10-index

Citations

Citations per year for Geoffrey Dusheiko1979: 1 citations1980: 2 citations1981: 1 citations1982: 4 citations1983: 4 citations1984: 9 citations1985: 8 citations1986: 8 citations1987: 12 citations1988: 11 citations1989: 5 citations1990: 8 citations1991: 7 citations1992: 5 citations1993: 19 citations1994: 50 citations1995: 49 citations1996: 40 citations1997: 74 citations1998: 78 citations1999: 87 citations2000: 115 citations2001: 123 citations2002: 132 citations2003: 118 citations2004: 96 citations2005: 103 citations2006: 94 citations2007: 94 citations2008: 103 citations2009: 99 citations2010: 111 citations2011: 138 citations2012: 185 citations2013: 180 citations2014: 213 citations2015: 178 citations2016: 208 citations2017: 148 citations2018: 155 citations2019: 612 citations2020: 620 citations2021: 637 citations2022: 458 citations2023: 381 citations2024: 632 citations2025: 260 citations2026: 6 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,969 citing papers, 19.2% of this breakdownUnited Kingdom: 807 citing papers, 7.9% of this breakdownChina: 805 citing papers, 7.8% of this breakdownGermany: 635 citing papers, 6.2% of this breakdownItaly: 612 citing papers, 6% of this breakdownFrance: 598 citing papers, 5.8% of this breakdownSpain: 386 citing papers, 3.8% of this breakdownCanada: 345 citing papers, 3.4% of this breakdownJapan: 345 citing papers, 3.4% of this breakdownAustralia: 314 citing papers, 3% of this breakdownTaiwan: 216 citing papers, 2.1% of this breakdownSwitzerland: 202 citing papers, 2% of this breakdown
0%19.2%Other 29.4%

Fields

  • Medicine88%
  • Immunology and Microbiology5.3%
  • Biochemistry, Genetics and Molecular Biology4.2%
  • Pharmacology, Toxicology and Pharmaceutics0.4%
  • Neuroscience0.4%
  • Health Professions0.2%
  • Other1.5%

Topics

  • Hepatitis C virus research21.1%
  • Hepatitis B Virus Studies16.1%
  • Liver Disease Diagnosis and Treatment11.9%
  • Hepatitis Viruses Studies and Epidemiology3.5%
  • Liver Disease and Transplantation3.4%
  • HIV/AIDS drug development and treatment3.2%
  • Other40.8%

Coauthors

All papers

Open in search
  1. The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alison Taylor, Tim Rhodes, Carla Treloar, Claus Petersen, Christoph Schramm, Robert Flisiak, Marieta Y Simonova, Albert Pares, Philip Johnson, Alessandro Cucchetti, Isabel Graupera, Christos Lionis, Elisa Pose, Núria Fabrellas, Ann T Ma, Juan M Mendive, Vincenzo Mazzaferro, Harry Rutter, Helena Cortez-Pinto, Deirdre Kelly, Robyn Burton, Jeffrey V Lazarus, Pere Ginès, Maria Buti, Philip N Newsome, Patrizia Burra, Michael P Manns - The Lancet 2021 cited by 627

  2. EASL recommendations on treatment of hepatitis C: Final update of the series☆

    Authors: , , , , , , , , - Journal of Hepatology 2020 cited by 1,226

  3. Hepatitis B virus infection

    Authors: , , , , , , , - Nature Reviews Disease Primers 2018 cited by 814

  4. Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy

    Authors: , , , , - Clinical Microbiology Reviews 2020 cited by 563

  5. openalex_id:w4200584065

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alison Taylor, Tim Rhodes, Carla Treloar, Claus Petersen, Christoph Schramm, Robert Flisiak, Marieta Simonova, Albert Parés, Philip J. Johnson, Alessandro Cucchetti, Isabel Graupera, Christos Lionis, Elisa Pose, Núria Fabrellas, Ann T., Juan Manuel Mendive, Vincenzo Mazzaferro, Harry Rutter, Helena Cortez‐Pinto, Déirdre Kelly, Robyn Burton, Jeffrey V. Lazarus, Pere Ginès, Marı́a Buti, Philip N. Newsome, Patrizia Burra, Michael P. Manns cited by 245

  6. Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2019 cited by 358

  7. New Approaches to Chronic Hepatitis B

    Authors: , , - New England Journal of Medicine 2023 cited by 168

  8. EASL Recommendations on Treatment of Hepatitis C 2018

    Authors: , , , , , , , , - Journal of Hepatology 2018 cited by 2,839

  9. Hepatitis B virus infection in children and adolescents

    Authors: , , , , , , , , , , , , , , - ˜The œLancet. Gastroenterology & hepatology 2019 cited by 257

  10. Hepatitis C

    Authors: , , , - The Lancet 2019 cited by 411

  11. Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets

    Authors: , , , , , , , , , , , , , , , , , , , , , - ˜The œLancet. Gastroenterology & hepatology 2017 cited by 368

  12. Pregenomic HBV RNA and Hepatitis B Core‐Related Antigen Predict Outcomes in Hepatitis B e Antigen–Negative Chronic Hepatitis B Patients Suppressed on Nucleos(T)ide Analogue Therapy

    Authors: , , , , , , , - Hepatology 2019 cited by 171

  13. Natural history of hepatitis C

    Authors: , - Journal of Hepatology 2014 cited by 1,040

  14. IL-10–Producing Regulatory B Cells in the Pathogenesis of Chronic Hepatitis B Virus Infection

    Authors: , , , , , , , , , , , , , , - The Journal of Immunology 2012 cited by 334

  15. Hepatitis B cure: From discovery to regulatory approval

    Authors: , , , - Hepatology 2017 cited by 341

  16. Upregulation of the Tim-3/Galectin-9 Pathway of T Cell Exhaustion in Chronic Hepatitis B Virus Infection

    Authors: , , , , , , , , , , , - PLoS ONE 2012 cited by 271

  17. Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease

    Authors: , , , , , , , , , , , , , - Gut 2010 cited by 345

  18. Blockade of Immunosuppressive Cytokines Restores NK Cell Antiviral Function in Chronic Hepatitis B Virus Infection

    Authors: , , , , , , , , , , , - PLoS Pathogens 2010 cited by 255

  19. The role of cells refractory to productive infection in acute hepatitis B viral dynamics

    Authors: , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2007 cited by 135

  20. Hepatitis C in sub-Saharan Africa: the current status and recommendations for achieving elimination by 2030

    Authors: , , , , , , , , , , , , , , , , , , , , - ˜The œLancet. Gastroenterology & hepatology 2017 cited by 157

  21. Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection

    Authors: , , , , , , , , , , - Hepatology 2011 cited by 312

  22. Pregnancy and liver disease

    Authors: , , - Journal of Hepatology 2015 cited by 257

  23. Temporal Analysis of Early Immune Responses in Patients With Acute Hepatitis B Virus Infection

    Authors: , , , , , , , , , , , , , - Gastroenterology 2009 cited by 360

  24. Advancing Age and Comorbidity in a US Insured Population‐Based Cohort of Patients With Chronic Hepatitis B

    Authors: , , , , , , , - Hepatology 2018 cited by 87